Sfoglia per RIVISTA
FRONTIERS IN ONCOLOGY
Collezione AO Ordine Mauriziano

  

Items : 11

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study. in Frontiers in oncology / Front Oncol. 2024 Feb 12;14:1307635. doi: 10.3389/fonc.2024.1307635. eCollection 2024.

2024
ASL Cuneo 2
AO Ordine Mauriziano

Chiellino S; Galli L; Banna GL; Fornarini G; Rescigno P; Cremante M; Damassi A; Catalano F; Roviello G; Cavo A; Lipari H; Vignani F; Prati G; Spada M; Nolè F; Morelli F; Di Napoli M; Caffo O; Malgeri A; Atzori F; Prati V; Tudini M; Sorarù M; Mollica V; Ricotta R; Baldessari C; Procopio G; Milella M; Fratino L; et alii...

Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2023 Sep 14;13:1247291. doi: 10.3389/fonc.2023.1247291. eCollection 2023.

2023
AO Ordine Mauriziano

Mangili G; Artioli G; Mammoliti S; Bartoletti M; Arezzo F; Tuninetti V; Scotto G; Giannone G; Castaldo D; Turinetto M; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G;

Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2023 Aug 7;13:1232476. doi: 10.3389/fonc.2023.1232476. eCollection 2023.

2023
AO Ordine Mauriziano

Zamagni C; Colombo N; Valabrega G; Savarese A; Sabbatini R; De Giorgi U; Gadducci A; Pignata S; Masi G; Danesi R; Locati LD; Lorusso D;

Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial. in Frontiers in oncology / Front Oncol. 2022 Sep 15;12:925366. doi: 10.3389/fonc.2022.925366. eCollection 2022.

2022
AO Ordine Mauriziano
AO Cuneo
ASL Cuneo 1
AOU Alessandria

Mariani G; Di Pede P; Spinelli GP; Santini D; Zustovich F; Bossi P; Di Maio M; Numico G; Gunnellini M; Rossi M; Giordano M; Corsi DC; Fabi A; Berruti A; Coletta D; Sbrana A; Galli L; Miccinesi G; Velutti L; Sammarco E; Roila F; Antonuzzo A; Ripamonti CI;

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The ?-Meet-URO analysis. in Frontiers in oncology / Front Oncol. 2022 Sep 23;12:955501. doi: 10.3389/fonc.2022.955501. eCollection 2022.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Buti S; Fornarini G; Banna GL; Porta C; Llaja Obispo MA; Roviello G; Cavo A; Vignani F; Nolè F; Caffo O; Messina M; Morelli F; Prati G; Soto Parra HJ; Atzori F; Di Napoli M; Santoni M; Cortellini A; Prati V; Massari F; Sorarù M; Panni S; Fratino L; Sabbatini R; Ricotta R; Boccardo F; Milella M; Procopio G; Zucali PA; et alii...

Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2022 Sep 21;12:979519. doi: 10.3389/fonc.2022.979519. eCollection 2022.

2022
AO Ordine Mauriziano

Danesi R; Locati LD; Zamagni C; Valabrega G; Savarese A; Sabbatini R; Gadducci A; Pignata S; De Giorgi U; Masi G; Colombo N; Lorusso D;

Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers. in Frontiers in oncology / Front Oncol. 2022 Jun 30;12:883344. doi: 10.3389/fonc.2022.883344. eCollection 2022.

2022
AOU Città della Salute di Torino
AO Ordine Mauriziano

Mariani L; Pace L; Ferraioli D; Cosma S; Preti M; Gallio N; Piovano E; Cassoni P; Bertero L; Biglia N; Benedetto C; Borella F;

Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey. in Frontiers in oncology / Front Oncol. 2022 May 27;12:880008. doi: 10.3389/fonc.2022.880008. eCollection 2022.

2022
AO Ordine Mauriziano

Pignata S; Valabrega G; Ronzino G; Pisano C; Di Maio M; Savarese A; Zamagni C; Artioli G; Lorusso D; Cormio G; Salutari V; Mangili G; Mammoliti S; Bartoletti M; Valsecchi AA; Turinetto M; Scotto G; Tuninetti V; Giannone G; Castaldo D;

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b). in Frontiers in oncology / Front Oncol. 2021 Jun 8;11:682449. doi: 10.3389/fonc.2021.682449. eCollection 2021.

2021
AO Ordine Mauriziano

Stellato M; Santini D; Verzoni E; De Giorgi U; Pantano F; Casadei C; Fornarini G; Maruzzo M; Sbrana A; Di Lorenzo G; Soraru M; Naglieri E; Buti S; De Vivo R; Napolitano A; Vignani F; Mucciarini C; Grillone F; Roviello G; Di Napoli M; Procopio G;

Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic. in Frontiers in oncology / Front Oncol. 2020 Apr 30;10:648. doi: 10.3389/fonc.2020.00648. eCollection 2020.

2020
AO Ordine Mauriziano

Fratino L; Procopio G; Di Maio M; Cinieri S; Leo S; Beretta G;

Residual Peripheral Blood CD26(+) Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission. in Frontiers in oncology / Front Oncol. 2018 May 30;8:194. doi: 10.3389/fonc.2018.00194. eCollection 2018.

2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Bocchia M; Sicuranza A; Abruzzese E; Iurlo A; Sirianni S; Gozzini A; Galimberti S; Aprile L; Martino B; Pregno P; Sorà F; Alunni G; Fava C; Castagnetti F; Puccetti L; Breccia M; Cattaneo D; Defina M; Mulas O; Baratè C; Caocci G; Sica S; Gozzetti A; Luciano L; Crugnola M; Annunziata M; Tiribelli M; Pacelli P; Ferrigno I; et alii...